Merck and Daiichi Sankyo forge $5.5 billion cancer drug allianceOctober 20, 2023 Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop…
